KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Ken Kato

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 7건 중 1-7 번을 표시중입니다.

1 Article A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data 강윤구 ; 유민희 ; Do?Youn Oh ; et al 2020
2 Article Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study Yoon-Koo Kang ; Satoshi Morita ; Taroh Satoh ; et al 2022
3 Article Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab · Li?Tzong Chen ; · Li?Yuan Bai1 ; · Taihei Nishiyama ; et al 2021
4 Article Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial Yoon-Koo Kang ; Li-Tzong Chen ; Min-Hee Ryu ; et al 2022
5 Article Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer 김성배 ; Antoine Adenis ; Chih-Hung Hsu ; et al 2020
6 Article Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3) Morihito Okada ; Ken Kato ; Byoung Chul Cho ; et al 2022
7 Article Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study Lin Shen ; Ken Kato ; Sung-Bae Kim ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.